Previous 10 | Next 10 |
Shares of biotech company Orgenesis ( NASDAQ: ORGS ) slumped nearly 31% to a daily low of $1.43 on Thursday after announcing stock and warrants offering to raise $3.7 million. ORGS entered into a securities purchase agreement for purchase and sale of 1,947,368 of its common stock,...
GERMANTOWN, Md., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Orgenesis, Inc. (Nasdaq: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it has entered into a securities p...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday! Moving stocks this morning are heavy pre-market trading...
GERMANTOWN, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, and Kurve Therapeutics, a next-generation medtech...
Orgenesis (ORGS) Q3 2022 Earnings Conference Call November 11, 2022 08:00 ET Company Participants David Waldman - Investor Relations Vered Caplan - Chief Executive Officer Neil Reithinger - Chief Financial Officer Conference Call Participants Bruce Ja...
Orgenesis press release ( NASDAQ: ORGS ): Q3 GAAP EPS of $0.05. Cash and cash equivalents of $3.01M For further details see: Orgenesis GAAP EPS of $0.05
Secures up to $50 Million of Funding from Metalmark Capital Partners Expected to Accelerate Rollout of Point-of-Care Services Reduces operating expenses by 49% to achieve nearly breakeven income from operation for the third quarter of 2022 Orgenesis to Host Conference ...
GERMANTOWN, Md., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will host a conference ...
Orgenesis ( NASDAQ: ORGS ) and Metalmark Capital Partners announced an investment partnership whereby Metalmark has agreed to make a growth investment of up to $50M in Orgenesis. The investment will be made at a pre-money valuation of $125M and will consist of an upfront i...
GERMANTOWN, Md., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) at the point of care, and Metalmark Capita...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.7% to $127.255 on volume of 88,797,787 shares Ascent Solar Technologies Inc (ASTI) rose 9.6% to $0.1183 on volume of 88,651,038 shares Crown Electrokinetics Corp. (CRKN) fell 19.0% to $0.040499 on volu...